This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: University of Southampton, Karus Therapeutics Limited. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: Graham Keith Packham: Innovator in Therapeutic Compounds
Introduction
Graham Keith Packham is a notable inventor based in Wiltshire, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the area of depsipeptides. With a total of 3 patents to his name, Packham's work has implications for the treatment of various diseases.
Latest Patents
Packham's latest patents include innovative compounds that focus on the therapeutic use of depsipeptides. One of his patents describes a compound of the general structure (VII) or (VIII), which includes isosteres and pharmaceutically acceptable salts. This compound features amino-acid side chain moieties and is designed to chelate zinc in the active site of histone deacetylases (HDAC). Another patent details Spiruchostatin analogues that inhibit HDAC, showcasing the versatility and potential of his inventions in medical applications.
Career Highlights
Throughout his career, Graham Keith Packham has worked with esteemed institutions such as the University of Southampton and Karus Therapeutics Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic research.
Collaborations
Packham has collaborated with notable individuals in his field, including Arasu Ganesan and Alexander Richard Liam Cecil. These partnerships have likely enriched his research and expanded the impact of his inventions.
Conclusion
Graham Keith Packham stands out as a significant figure in the realm of therapeutic innovations. His patents and collaborations reflect his commitment to advancing medical science through inventive solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
